A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2001
11/08/2001	CA2409219A1 Cellular regulators of infectious agents and methods of use
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2407970A1 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407945A1 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
11/08/2001	CA2407942A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
11/08/2001	CA2407824A1 Pharmaceutical composition
11/08/2001	CA2407797A1 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	CA2407785A1 Use of .alpha.-msh and epo for preventing or treating ischemic conditions
11/08/2001	CA2407781A1 Ceruloplasmin and uses thereof in neurodegenerative related conditions
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407740A1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/08/2001	CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407669A1 Treatment of damaged connective tissue
11/08/2001	CA2407656A1 Myocardial cell proliferation-associated genes
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407595A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2407235A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2407134A1 Cancer therapy
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2378001A1 Preparation for nasal absorption of insulin
11/08/2001	CA2346616A1 Stabilized protein preparation and process for its preparation
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152056A1 Method for modifying genetic characteristics of an organism
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152011A1 Peptides inhibiting vascular endothelial cell migration
11/07/2001	EP1151755A1 Pharmaceutical compositions comprising cyclosporin as active ingredient
11/07/2001	EP1151746A1 Microcapsules for sustained release of drugs
11/07/2001	EP1151141A1 A method of treating anemia
11/07/2001	EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151109A1 Fucosyl transferase gene
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis
11/07/2001	EP1151105A1 Neisseria meningitidis serogroup b antigen
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151100A1 Tau-conotoxin peptides
11/07/2001	EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151092A1 Inhibiting formation of atherosclerotic lesions
11/07/2001	EP1151089A1 Catalytic molecules
11/07/2001	EP1151088A1 Improved phytases
11/07/2001	EP1151083A1 Nitroreductase enzymes
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151009A2 Antimicrobial/endotoxin neutralizing polypeptide
11/07/2001	EP1151008A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
11/07/2001	EP1151006A1 Human g protein coupled receptor
11/07/2001	EP1151004A1 Method for producing il-1ra, a therapeutically active protein from body fluids
11/07/2001	EP1151001A2 Method for altering undesirable immune responses to polypeptides
11/07/2001	EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150996A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/07/2001	EP1150995A1 A synthetic peptide disturbing intracellular signaling
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150957A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
11/07/2001	EP1150918A2 Therapeutic calcium phosphate particles and methods of manufacture and use
11/07/2001	EP1150726A1 Highly-mineralized osteogenic sponge compositions, and uses thereof
11/07/2001	EP1150725A1 Osteogenic paste compositions and uses thereof
11/07/2001	EP1150717A1 Sustained release salts of pharmaceutically active peptides and their production
11/07/2001	EP1150716A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
11/07/2001	EP1150714A2 Methods for inhibiting brain tumor growth
11/07/2001	EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
11/07/2001	EP1150705A2 Protection of cells in connection with treatment with chemical agents
11/07/2001	EP1150704A1 New use of melagatran
11/07/2001	EP1150703A1 Chaperonin 10 and beta-interferon therapy of multiple sclerosis
11/07/2001	EP1150702A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation
11/07/2001	EP1150701A2 Homing pro-apoptotic conjugates and methods of using same
11/07/2001	EP1150700A1 Antiangiogenic drugs
11/07/2001	EP1150699A1 Treatment of bladder and gastrointestinal mastocytosis
11/07/2001	EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
11/07/2001	EP1150696A2 Treatment of tumors with genetically engineered herpes virus
11/07/2001	EP1150693A1 Immunogenic compositions for use as vaccines
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150688A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
11/07/2001	EP1150684A1 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
11/07/2001	EP1150678A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
11/07/2001	EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease
11/07/2001	EP1150664A2 Novel use of orexin receptor antagonists
11/07/2001	EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
11/07/2001	EP1042312B1 PHOTOCHROMIC INDENO-FUSED NAPHTHO[2,1-b]PYRANS
11/07/2001	EP1014956A4 Methods of using integrin modulators
11/07/2001	EP1011648B1 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/07/2001	EP1003532B1 Lactobacilli to increase absorption of minerals by intestinal cells
11/07/2001	EP0980205A4 Method of treating malignancies
11/07/2001	EP0975380B1 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
11/07/2001	EP0921812B1 Insulin preparations containing a halogenide
11/07/2001	EP0918469B1 Methods and compositions for increasing the anaerobic working capacity in tissues
11/07/2001	EP0845007B1 Pharmaceutical composition containing inhibitors of interferon-gamma
11/07/2001	EP0835108B1 Use of lamellarin-class alkaloids in methods of treatment
11/07/2001	EP0824699B1 Compounds and methods for diagnosis of leishmaniasis

1 ... 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 ... 3163